Analysts fell to the sidelines weighing in on ChemoCentryx (CCXI – Research Report) and ATI Physical Therapy (ATIP – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
ChemoCentryx (CCXI)
In a report released today, Edward White from H.C. Wainwright maintained a Hold rating on ChemoCentryx, with a price target of $52.00. The company’s shares closed last Tuesday at $50.84, close to its 52-week high of $50.91.
According to TipRanks.com, White is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on ChemoCentryx is a Hold with an average price target of $49.00, representing a -3.7% downside. In a report issued on August 4, Piper Sandler also downgraded the stock to Hold with a $52.00 price target.
See today’s best-performing stocks on TipRanks >>
ATI Physical Therapy (ATIP)
Barrington analyst Michael Petusky maintained a Hold rating on ATI Physical Therapy today. The company’s shares closed last Tuesday at $0.95.
According to TipRanks.com, Petusky is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for ATI Physical Therapy.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CCXI:
